MADRID (Reuters) – Spain’s pharmaceutical firm Rovi, in charge of the “fill and finish” final stage of manufacturing for Moderna’s COVID-19 vaccine candidate outside the United States, said on Tuesday it expects to start producing the vaccine “very soon” if it is approved by regulators.
(Reporting by Emma Pinedo and Jess Aguado; editing by Andrei Khalip)
